MetLife Investment Management’s Trinseo TSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-18,073
Closed -$68.3K 2921
2024
Q1
$68.3K Sell
18,073
-1,004
-5% -$5.36K ﹤0.01% 2672
2023
Q4
$160K Buy
+19,077
New +$128K ﹤0.01% 2362
2023
Q3
Sell
-19,077
Closed -$242K 2979
2023
Q2
$242K Hold
19,077
﹤0.01% 2158
2023
Q1
$398K Hold
19,077
﹤0.01% 1789
2022
Q4
$433K Hold
19,077
﹤0.01% 1731
2022
Q3
$349K Buy
19,077
+901
+5% +$28.2K ﹤0.01% 1889
2022
Q2
$699K Sell
18,176
-2,524
-12% -$114K 0.01% 1430
2022
Q1
$992K Buy
20,700
+7,495
+57% +$394K 0.01% 1331
2021
Q4
$693K Hold
13,205
0.01% 1312
2021
Q3
$713K Hold
13,205
0.01% 1318
2021
Q2
$790K Sell
13,205
-2,046
-13% -$131K 0.01% 1301
2021
Q1
$971K Hold
15,251
0.01% 1171
2020
Q4
$781K Sell
15,251
-2,734
-15% -$104K 0.01% 1245
2020
Q3
$461K Hold
17,985
0.01% 1405
2020
Q2
$399K Hold
17,985
﹤0.01% 1505
2020
Q1
$326K Hold
17,985
﹤0.01% 1447
2019
Q4
$669K Hold
17,985
0.01% 1297
2019
Q3
$772K Hold
17,985
0.01% 1182
2019
Q2
$761K Hold
17,985
0.01% 1247
2019
Q1
$815K Buy
+17,985
New +$870K 0.01% 1177

Other funds holding TSE

MetLife Investment Management's TSE Position: Q2 2024 in Review

MetLife Investment Management sold out of Trinseo (TSE) in Q2 2024, closing a stake of 18,073 shares — an estimated $68.3K sold.

MetLife Investment Management first reported a position in TSE in Q1 2019 and held it in 20 quarters. The position peaked at $992K in Q1 2022. 97 funds tracked by Wall St. Rank hold TSE as of Q2 2024.

  • MetLife Investment Management reported no remaining Trinseo position as of Q2 2024 after selling out during the quarter.
  • MetLife Investment Management sold 18,073 Trinseo shares in Q2 2024, an estimated $68.3K.
  • MetLife Investment Management first reported a position in Trinseo in Q1 2019 and held it in 20 quarters.
  • MetLife Investment Management's Trinseo position peaked at $992K in Q1 2022.
  • 97 funds tracked by Wall St. Rank held Trinseo as of Q2 2024.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.